Physician profile
Terry D Fenwick
NPI 1881674364
$2,330.97
in general payments reported to CMS, 2019-2025
9 companies · $814 in 2025
The $814 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.64 · 2021: $24.74 · 2022: $1,272 · 2024: $188 · 2025: $814.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615 · Travel and Lodging: $387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.11 |
| Travel and Lodging | $386.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Crossroads Orthopedics, LLC | $1,258.57 | 2022 | |
| Sonex Health, INC. | $911.59 | 2024-2025 | Sx-One Microknife |
| Ferring Pharmaceuticals INC. | $52.77 | 2024-2025 | Euflexxa |
| Alpha Orthopedic Systems | $32.64 | 2019 | |
| Innovation Technologies INC | $24.16 | 2025 | Irrisept |
| Kowa Pharmaceuticals America, INC. | $13.30 | 2022 | |
| Orthofix Medical, INC. | $13.20 | 2025 | Physio-Stim |
| Bioventus LLC | $12.37 | 2021 | |
| Depuy Synthes Sales INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terry Fenwick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.